The legal landscape for psilocybin has shifted significantly since 2020. Here is the current status in every state where psilocybin has been addressed by law or ballot measure.
Licensed service centers can provide psilocybin to adults 21+ with licensed facilitators. No prescription or diagnosis required. Sessions take place only at approved facilities. Personal possession outside service centers is not protected under Measure 109.
Colorado's "natural medicine" framework is more expansive than Oregon's. Personal possession and home cultivation of psilocybin mushrooms (and other natural medicines including ibogaine, DMT, mescaline) is legal for adults 21+. Licensed healing centers provide facilitated sessions. Commercial sale remains prohibited — gifts are allowed.
California SB 58 decriminalized personal possession of psilocybin, DMT, mescaline, and ibogaine for adults 21+. This means you will not be prosecuted for possession, but there are no legal service centers or regulated therapy programs statewide (as of 2026). San Francisco, Oakland, and Berkeley had previously decriminalized through city ordinances.
Many states have individual cities that have passed local decriminalization ordinances, making psilocybin possession a low or no enforcement priority. This does not override state or federal law — it means local police won't prioritize enforcement. See the city list below for details.
The two states with operational psilocybin programs have taken meaningfully different approaches. Understanding the differences matters for both users and policymakers watching what model other states adopt.
| Feature | Oregon (Measure 109) | Colorado (Prop 122) |
|---|---|---|
| Personal possession | Not protected | Legal for adults 21+ |
| Home cultivation | Not legal | Legal for personal use |
| Substances covered | Psilocybin only | Psilocybin, psilocin, DMT, ibogaine, mescaline |
| Service model | Licensed service centers | Licensed healing centers |
| Medical diagnosis required? | No | No |
| Prescription required? | No | No |
| Age minimum | 21+ | 21+ |
| Gifting (person-to-person) | Not addressed | Legal (non-commercial) |
| Commercial sale | Prohibited (only at service centers) | Prohibited |
| Typical session cost (2026) | $1,500 – $3,500 | $1,200 – $3,000 |
| Medicare/insurance coverage | No | No |
More than 20 US cities have passed local ordinances making psilocybin possession a lowest or no enforcement priority. This does not create legal therapy programs — it only reduces risk of local prosecution for personal possession. Federal law (Schedule I) continues to apply.
A city decriminalization ordinance means local police deprioritize arrests for personal possession. State police, federal agents, and federal law are unaffected. You can still be charged under state or federal law. And you still cannot legally buy, sell, or run a business involving psilocybin in a decriminalized city without state authorization.
OOTWOracle's 8-agent AI system runs daily confidence scoring on which states will pass regulated psilocybin access frameworks before January 2028. These scores reflect probability assessments based on political alignment, legislative activity, ballot initiative campaigns, and research institution presence.
AB 941 therapy bill in circulation. SB 58 decrim already passed. Large psychedelic research community (UCSF, UCLA). Political will is present — the question is legislative timing and implementation framework.
NY A01583 and multiple companion bills active in Albany. NYU Langone's psychedelic research center produces supportive data. NYC has strong advocacy community. Major barrier: state Senate Republican caucus.
Multiple city decrim ordinances. Natural Medicine Health Act ballot measure effort underway. Harvard and Boston area research institutions are supportive. 2026 ballot measure campaign in progress.
Seattle city decrim 2021. SB 5263 pilot program bill passed in modified form. University of Washington research. Strong progressive political environment in Seattle. State-level implementation slower than expected.
Minneapolis decrim 2022. Minnesota SF 2440 natural medicine bill has had hearings. DFL-controlled legislature in 2025-2026 session is the key window. Cannabis legalization precedent is favorable.
Strong veteran advocacy (MAPS research center in Scottsdale). Republican-controlled legislature is a barrier for broad decrim but veteran PTSD framing has bipartisan appeal. Ibogaine angle (Texas precedent) may create opening.
You cannot legally purchase psilocybin mushrooms anywhere in the US in 2026. In Oregon and Colorado, you can pay for a facilitated session at a licensed service center or healing center — but this is a service fee, not a purchase of mushrooms. In Colorado, you can also receive mushrooms as a gift from another adult (non-commercial transfer). You cannot walk into a store and buy psilocybin mushrooms in any US state.
Only in Colorado under Proposition 122, which specifically permits personal cultivation of psilocybin mushrooms for adults 21+ for personal use (not sale or distribution). In every other US state, home cultivation of psilocybin mushrooms violates state and federal law. Note: growing spores for microscopy is often sold legally online, but inoculating those spores and growing mushrooms crosses into illegal manufacturing in most states.
In a decriminalized city, local police will likely not arrest you or seize your mushrooms for personal-use quantities. However: (1) state law still technically applies — a state police officer or state prosecutor can still charge you; (2) federal law (Schedule I) still applies; (3) you have no legal protection for larger quantities. Decriminalization is a discretionary non-enforcement policy, not an immunity or a legal right. The practical risk is low in strongly decriminalized cities, but the legal risk is not zero.
Oregon's Measure 109 created a "psilocybin services" model, not a medical model. You do not need a doctor, prescription, or diagnosis. You work with a licensed facilitator (who is not a medical professional) at a licensed service center. Sessions are wellness/personal growth oriented. This is similar to a therapeutic retreat model — it is regulated but not medicalized. This is fundamentally different from Australia's TGA model, where only psychiatrists can prescribe psilocybin as a medical treatment for treatment-resistant depression.
OOTWOracle gives a 31% probability of US federal psilocybin approval by 2029. The most likely path is FDA approval of a specific psilocybin compound for a specific indication (e.g., COMPASS Pathways' COMP360 for treatment-resistant depression or Usona Institute's psilocybin for MDD), followed by DEA rescheduling under the Controlled Substances Act. The fastest realistic timeline, assuming a successful Phase 3 NDA submission in 2026-2027, would be 2028-2029. Oregon/Colorado state programs do not affect the federal schedule.
Psilocybin retreats are legal only if they operate within the Oregon or Colorado regulated frameworks. In Oregon, a "retreat" would need to be licensed as a service center with licensed facilitators. Outside these frameworks, retreats that provide psilocybin are operating in a legal grey area or illegally. Many retreat operators advertise "guided experiences" outside the US (Jamaica, Netherlands, Mexico) where psilocybin is legal or tolerated — these are legal but subject to the laws of those countries, not US law.
OOTWOracle's 8-agent AI system monitors state legislative calendars, FDA signals, DEA scheduling actions, and Congressional bills — every day. Get confidence-scored predictions on what happens next.
Oracle Chamber → Psilocybin FDA Tracker →More OOTWOracle deep-dives on psychedelic medicine regulation: